These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4559161)
21. [Therapeutic methods with a new xanthine derivative in peripheral and central circulatory disorders]. Mansfeld HG Dtsch Med J; 1972 Jan; 23(1):49-53. PubMed ID: 5060262 [No Abstract] [Full Text] [Related]
22. [Effect of a new vasotherapeutic agent 3,7-dimethyl-1-(oxo-hexyl)-xanthine on lipid metabolism: lipolysis in adipose tissue]. Granzer E Arzneimittelforschung; 1972 Aug; 22(8):1407-10. PubMed ID: 4678402 [No Abstract] [Full Text] [Related]
23. [Management of cerebrovascular circulation disorders with Tropodil]. Steinbach M Med Klin; 1967 Feb; 62(7):257-9. PubMed ID: 5595330 [No Abstract] [Full Text] [Related]
24. The effects of intravenous administration of prostaglandin E1 on cerebral circulation in patients with cerebrovascular disease. Kuriyama Y; Nukada T; Aoyama T; Abe H Med J Osaka Univ; 1976 Mar; 26(3-4):111-6. PubMed ID: 979857 [No Abstract] [Full Text] [Related]
25. [Angiographic study of the action of pervincamine on cerebral circulation]. Baiano G; Elefante R; Granata F; Graziussi G Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048 [No Abstract] [Full Text] [Related]
26. [Studies on the effect of a new coronary vessel dilating substance, carbochromen, on the blood circulation and metabolism of the brain]. Yamaoka S; Okada T; Kawamura M; Saito Y Med Welt; 1968 Mar; 12():764-70. PubMed ID: 5728935 [No Abstract] [Full Text] [Related]
27. [Clinico-rheographical correlations in patients with cerebrovascular disorders treated with intravenous cinnarizine]. Lebiediewa NW; Pletniewa LW; Kozłowa EN; Wysocka-Bakowska MM Neurol Neurochir Pol; 1981; 15(4):423-30. PubMed ID: 7329508 [TBL] [Abstract][Full Text] [Related]
28. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)]. Pires de Oliveira RS Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581 [No Abstract] [Full Text] [Related]
29. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345 [TBL] [Abstract][Full Text] [Related]
30. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases]. Kauchtschischvili G; Nappi G; Bono G Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671 [No Abstract] [Full Text] [Related]
31. [Effect of methindione on the bioelectric activity of the brain, on cerebral circulation and on psychic disorders in epilepsy]. Kamianov IM; Grinberg ZR; Andrezinia RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):879-84. PubMed ID: 5050045 [No Abstract] [Full Text] [Related]
32. [Effects of nicotinic acid on cerebral and peripheral blood supply in attacks (rheoencephalographic and oscillographic studies)]. Hadjiev D Psychiatr Neurol Med Psychol (Leipz); 1965 Aug; 17(8):291-6. PubMed ID: 5847589 [No Abstract] [Full Text] [Related]
33. [Statistical studies on the results of stroke therapy]. Eichhorn O; Auell KH; Dörfler L Med Klin; 1965 Dec; 60(52):2100-4. PubMed ID: 5333324 [No Abstract] [Full Text] [Related]
34. [Clinical study of Pervincamine in a general medicine department]. Vialette G; Argullos J Lyon Med; 1972 Apr; 227(8):773-6. PubMed ID: 4558729 [No Abstract] [Full Text] [Related]
36. [Complex experimental and clinical study of the effect of nitroglycerin on the cerebral, peripheral and systemic circulations]. Anzimirov VL; Gasanov IaK; Kornienko VN; Mirzoian RS Farmakol Toksikol; 1980; 43(6):683-7. PubMed ID: 6778711 [TBL] [Abstract][Full Text] [Related]
37. [Therapy of cerebral ictus by continuous intravenous perfusion of bamethan]. Piovella C; Galli C; Torti G Clin Ter; 1972 Feb; 60(3):217-28. PubMed ID: 4146838 [No Abstract] [Full Text] [Related]
38. [Treatment of circulatory encephalopathy with Cavinton]. Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359 [No Abstract] [Full Text] [Related]
39. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases]. Hess H; Franke I; Jauch M Fortschr Med; 1973 Jun; 91(17):743-8. PubMed ID: 4577522 [No Abstract] [Full Text] [Related]
40. [Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine]. Nolte D Arzneimittelforschung; 1971 Oct; 21(10):1453-6. PubMed ID: 5171859 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]